ASP7374 clinical trials
Also written ASP7374.
How each study uses ASP7374 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- ASP7374
- 5
Studies by the year they started
5 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses ASP7374 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Study to Evaluate Intramuscular ASP7374CompletedPhase 3UMN Pharma Inc.NCT01961960Written as ASP7374
- A Study to Assess the Safety of ASP7374 in Adult Subjects Aged 20 or OlderCompletedPhase 3UMN Pharma Inc.NCT02366962Written as ASP7374
- Phase-3 Study of ASP7374, Cell-culture-derived Influenza VaccineCompletedPhase 3UMN Pharma Inc.NCT01767896Written as ASP7374
- A Study to Evaluate the Immune Response to the ASP7374 and Its Safety in Healthy Adult VolunteersCompletedPhase 1/2UMN Pharma Inc.NCT01393951Written as ASP7374
- Study of ASP7374, Cell-culture-derived Influenza VaccineCompletedPhase 3UMN Pharma Inc.NCT01961947Written as ASP7374